AI adoption by physicians has surged to over 80%, yet many express balanced views, excited by potential but concerned about ...
In a Rwanda-based evaluation, LLM judges produced consistent and far cheaper ratings of clinical AI responses but matched ...
OpenEvidence and Doximity are touting dueling NOHARM benchmark wins, the latest round in a wave of clinical AI safety studies with conflicting results.
On July 14, the U.S. Food and Drug Administration (FDA) announced it is seeking public input regarding the patient safety impacts of certain ...
Making clinical decision-making is often a team effort. Patients seeking cancer treatment, for instance, may have a surgeon, ...
Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis?
Alexandria now includes 33M precision Evidence-Based Findings (pEBF™) growing to more than two billion studies in 2026, exceeding evidence-based findings in all public medical literature; Meta, ...
The court displayed its independence in what was a stinging rebuke to President Trump, though the ruling is unlikely to have an immediate effect on prices. By The New York Times See more of our ...
While the integration of modern AI systems in clinical practice is currently in the process of transforming how medicine is being practiced, the focus of most research activities lies on AI-associated ...
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the other related to clinical decision ...
Multi-AI agents – multiple artificial intelligence agents working together in a shared environment – can be used to address persistent workflow challenges in clinical decision support, drawing from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results